Elective Percutaneous Coronary Intervention With or Without Supplemental OXYgen (EPOXY-IMR)
Elective Percutaneous Coronary Intervention With or Without Supplemental OXYgen and Evaluation of Effects on Coronary Microcirculation Using the Index of Microcirculatory Resistance
Sponsor: Karolinska Institutet
Terminated
Slow recruitment
Other terminated trials from Karolinska Institutet
Other Coronary Artery Disease trials with similar outcome
A PHASE3 clinical study on Coronary Artery Disease, this trial is terminated or withdrawn. The trial is conducted by Karolinska Institutet and has accumulated 8 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Mar 2019 — Oct 2020 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Mar 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Karolinska Institutet
For direct contact, visit the study record on ClinicalTrials.gov .